Рет қаралды 2,837
During antibody discovery, researchers characterize and optimize thousands of antibody molecules to select ideal drug candidates. Artificial intelligence/machine learning (AI/ML) technologies provide new opportunities for identifying and generating high-quality antibody drugs in less time.
In this webinar, Charbel Eid, from BigHat Biosciences, will discuss an innovative AI/ML platform that guides antibody design and accelerates the discovery of better antibody therapeutics. Learn more at idtb.io/4xsnkb